Steven H. Stein - Jul 14, 2023 Form 4 Insider Report for INCYTE CORP (INCY)

Role: EVP & Chief Medical Officer
Signature: /s/ Elizabeth Feeney, Attorney-In-Fact
Stock symbol: INCY
Transactions as of: Jul 14, 2023
Transactions value $: $0
Form type: 4
Date filed: 7/18/2023, 04:00 PM
Previous filing: Jul 6, 2023
Next filing: Aug 3, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INCY	Common Stock	Award	$0	+13.5K	+12.82%	$0.00	119K	Jul 14, 2023	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INCY	Employee Stock Option (right to buy)	Award	$0	+28.4K		$0.00	28.4K	Jul 14, 2023	Common Stock	28.4K	$61.76	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years, subject to Steven Stein's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis.
F2	Including the July 14, 2023 RSU Grant, this includes an aggregate of 87,659 shares of common stock issuable pursuant to previously RSUs and earned performance shares that have not vested.
F3	The July 14, 2023 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.